BEAMER ARGON PROBE

K081644 · Conmed Corporation · GEI · Sep 10, 2008 · General, Plastic Surgery

Device Facts

Record IDK081644
Device NameBEAMER ARGON PROBE
ApplicantConmed Corporation
Product CodeGEI · General, Plastic Surgery
Decision DateSep 10, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4400
Device ClassClass 2
AttributesTherapeutic, 3rd-Party Reviewed

Intended Use

The Beamer™ Argon Probes are indicated for argon enhanced coagulation of tissue.

Device Story

Beamer™ Argon Probe is a single-use endoscopic accessory designed for argon enhanced coagulation of tissue. Device consists of a stainless steel wire extending from a proximal connector to a distal electrode; electrode is housed within a ceramic tip to provide thermal insulation and prevent direct tissue contact. Probes are available in various lengths and diameters to suit specific endoscopic procedures. Device is used by physicians in clinical settings during endoscopic interventions. Operation involves delivering argon gas and electrical energy to the target tissue site to achieve coagulation. The ceramic tip protects the probe tubing from heat degradation during use. Probes are supplied sterile via ethylene oxide.

Clinical Evidence

No clinical data. Biocompatibility and bench testing were performed to demonstrate equivalence to predicate devices; all testing met predetermined performance specifications.

Technological Characteristics

Stainless steel wire conductor; ceramic tip for thermal insulation; ethylene oxide sterilization; single-use; various lengths and diameters; non-contact electrode design.

Indications for Use

Indicated for argon enhanced coagulation of tissue in patients requiring endoscopic procedures.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Ko 81644 ConMed Endoscopic Technologies Beamer™ Argon Probe Page 1 of 2 Image /page/0/Picture/3 description: The image shows the logo for CONMED Endoscopic Technologies. The logo features a stylized graphic to the left of the word "CONMED" in large, bold letters. Below "CONMED" is the phrase "ENDOSCOPIC TECHNOLOGIES" in smaller letters. The logo appears to be for a company that specializes in endoscopic technologies. SEP 1 0 2008 # 510(k) Summary of Safety and Effectiveness - 1. Sponsor Name: ConMed Endoscopic Technologies, Inc. 129 Concord Road Billerica, MA 01821 Telephone: 978-964-4232 FAX: 978-964-4230 Contact Individual: Karen Provencher Sr. Regulatory Affairs Specialist Preparation Date: March 10, 2008 - 2. Device Name: ConMed Beamer™ Argon Probe - 3. Identification of Predicate or Legally Marketed Device: ConMed ABC Probes for Flexible Endoscopes cleared under K990586 on May 17, 1999 ERBE Straight Fire & Side Fire Probes cleared under K013348 on October 26, 2001 Canady Plasma Probes for Flexible Endoscopy cleared under K052035 on August 31, 2005 ### 4. Device Description: The Beamer Argon Probe consists of a stainless steel wire that extends from the probe connector to the distal end of the probe. The proximal end of the stainless steel wire is soldered into the connector body. The distal end of the wire is crimped to an electrode located at the distal end of the probe. The distal end of the Beamer Argon Probe has a ceramic tip which provides a thermal insulation barrier for the tubing to prevent heat degradation during coagulation. The electrode remains recessed in the ceramic tip such that there is no tissue contact during the procedure. There are several configurations of the Beamer Argon Probe. The probes vary in length and outside diameter to accommodate the procedure performed by the physician. The Beamer Argon Probes are provided sterile by ethylene oxide and are single use only. #### 5. Intended Use: The Beamer™ Argon Probes are indicated for argon enhanced coagulation of tissue. Page 75 of 159 {1}------------------------------------------------ sib44 ConMed Endoscopic Technologies Beamer™ Argon Probe Page 2 of 2 ## 6. Comparison of Technological Characteristics: The Beamer Argon Probes are substantially equivalent to the predicate devices both in intended use, technological characteristics and materials. ### 7. Performance Testing: Biocompatibility and bench testing have been performed to demonstrate equivalence of the Beamer Argon Probes to their predicate devices. All testing passed the predetermined performance specifications. Page 76 of 159 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract design that resembles a stylized caduceus, a symbol often associated with medicine and healthcare. The design is composed of three curved lines that intersect and form a shape similar to a staff with snakes entwined around it. SEP 1 0 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ConMed Corporation % Intertek Testing Services Mr. Daniel W. Lehtonen 2307 East Aurora Road, Unit B7 Twinsburg, Ohio 44087 Re: K081644 Trade/Device Name: Beamer" Argon Probe Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: II Product Code: GEI Dated: August 28, 2008 Received: August 29, 2008 Dear Mr. Lehtonen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Mr. Daniel W. Lehtonen This letter will allow you to begin marketing your device as described in your Section 510(k) promarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket, Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Mark M. Millican Mark N. Melkerson Director Division of General. Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ConMed Endoscopic Technologies Beamer™ Argon Probe 81644 Image /page/4/Picture/2 description: The image shows the logo for CONMED Endoscopic Technologies. The logo features a stylized graphic to the left of the word "CONMED" in all caps. Below the word "CONMED" is the phrase "ENDOSCOPIC TECHNOLOGIES" in a smaller font size. ### C. INDICATION FOR USE 510(k) Number (if known) Device Name: Beamer™ Argon Probe Indication for Use: The Beamer™ Argon Probes are indicated for argon enhanced coagulation of tissue. Prescription Use X (Per 21 CFR 801 Subpart D) AND/OR Over the Counter Use (Per 21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY) Concurrence of CDRH, Office of Device Evaluation (ODE) ..... Mark A. Melkeren (Division Sign-Off) Division of General, Restorative, and Neurological Devices 510(k) Number 31644 Page 1 of 1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%